Legislation on biotechnology in the Nordic countries updated for 2019

Each year, the Nordic Committee on Bioethics publishes an updated overview of legislation within biotechnology in the Nordic countries. Given the clear need for such overviews, the committee decided to update the tables to reflect recent legal amendments.

The aim of this report is to give the reader information on the current status in the different countries and a chance to compare the legal situations. In this edition we have added two new topics; One is NIPT (Non-Invasive Prenatal Test). The other is Direct-to-consumer genetic testing (DTC-GT). DTC-GT was introduced to the private market without any formal procedures and remains to a large degree unregulated. As part of the national health care systems, the use of NIPT requires a formal process of approval, carried out either by the government or hospital. But also NIPT is offered as a private service.

You can download or order the report here
And find links to previous NCBio publications here



Read more

Report: Bioethics of clinical innovation and unproven methods Copenhagen, 9 April 2019

For 30 years the Nordic Committee on Bioethics has promoted Nordic cooperation and exchange of information between scientists, parliamentarians, and public officials in bioethics. On April 9, 2019 the Nordic Committee on Bioethics organised the conference Bioethics of clinical innovation and unproven methods in collaboration with Centre for Legal Studies in Welfare and Market at the University of Copenhagen. How are clinical innovations and unproven methods developed and introduced in western Nordic health-care systems? What is the legal and regulatory environment concerning unproven methods in medicine? What ethical principles should guide work on emerging treatments and experimentation in hospitals? These three questions were addressed in separate sessions in a day of fruitful discussions.

Read more

Report: Life-style diseases: Responsibility and Ethics, Helsinki, 11-12 June 2018

The NCBio-conference on Lifestyle diseases: Responsibility and Ethics took place in Helsinki 11 -12 June 2018.  Nearly 90 participants attended the conference.

The aim of the conference was to address the new emphasis on the individual’s responsibility and choices in view of collectivist health policies and solidary-based welfare systems. 

A full report from the conference can be found here.

Read more

Report: Updated version of Legislation on biotechnology in the Nordic countries

The current report is an update of the reports on Legislation on biotechnologyin the Nordic countries published annually since 2014. Given the clear need for such overviews, the Nordic Committee on Bioethics decided to update the tables to reflect recent legal amendments. The aim of this report is to give the reader information on the current status in the different countries and a chance to compare the legal situation.
Read more

Conference: Hard choices in Nordic Health Care

The Nordic Committee on Bioethics, in cooperation with the Swedish Society of Medicine, invited to a conference addressing Hard choices in Nordic Health Care. The conference took place 20 November 2016, in Stockholm, Sweden.
Read more

Conference: Biotechnology for a longer life

The Nordic Committee on Bioethics, in collaboration with the Centre for Collaborative Health at Aarhus University, organised a workshop on «Biotechnology for a longer life» in Aarhus, Denmark, 9 December 2016.

Read more

Conference: Biotechnology for a longer life

We want to live as long as possible, but at the same time many people fear growing old. Growing old means an increased risk of degenerative diseases, and of becoming fragile and dependent on others. Moreover, elderly people often find themselves isolated and without a well-defined role in society.
Read more